Fiedorczuk Piotr, Stróżyński Adam, Olszewska Ewa
Doctoral School of the Medical University of Bialystok, 15-328 Białystok, Poland.
Medical University of Bialystok, 15-328 Białystok, Poland.
J Clin Med. 2020 Nov 20;9(11):3734. doi: 10.3390/jcm9113734.
Obstructive sleep apnea (OSA) is a prevalent, underdiagnosed disease and is considered an independent risk factor for cardiovascular disease. The exact mechanism of cardiovascular complications (CVC) development as a complication of OSA is not entirely understood. Oxidative stress is suspected to be the essential factor in initiating various comorbidities in OSA. Biomarkers of nonenzymatic lipid and protein peroxidation, DNA repair and antioxidant capabilities measured in serum, plasma and urine are frequently used to assess the presence of oxidative stress. We conducted a systematic review and quality assessment of available observational analytic studies to determine whether there is an association between oxidative stress and OSA in patients with prevalent CV disease compared to (a) patients with prevalent CV disease but no OSA, (b) patients with prevalent CV disease and less severe OSA and (c) patients with OSA and no overt CV disease. This systematic review demonstrated that, while oxidative stress is associated with OSA, there was no clear difference in the severity of oxidative stress between OSA patients with or without cardiovascular complications.
阻塞性睡眠呼吸暂停(OSA)是一种常见但诊断不足的疾病,被认为是心血管疾病的独立危险因素。作为OSA并发症的心血管并发症(CVC)的确切发病机制尚未完全明确。氧化应激被怀疑是引发OSA各种合并症的关键因素。血清、血浆和尿液中测量的非酶脂质和蛋白质过氧化、DNA修复及抗氧化能力的生物标志物常被用于评估氧化应激的存在。我们对现有的观察性分析研究进行了系统评价和质量评估,以确定与(a)患有心血管疾病但无OSA的患者、(b)患有心血管疾病且OSA较轻的患者以及(c)患有OSA但无明显心血管疾病的患者相比,患有心血管疾病的患者中氧化应激与OSA之间是否存在关联。该系统评价表明,虽然氧化应激与OSA相关,但有或无心血管并发症的OSA患者之间氧化应激的严重程度并无明显差异。